Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Duncan

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of Drug Targeting|November 10, 2006
Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunitiesRuth Duncan, Helmut Ringsdorf, Ronit Satchi-Fainaro
Advanced Drug Delivery Reviews|August 18, 2009
Polymer therapeutics: clinical applications and challenges for developmentMaría J Vicent, Helmut Ringsdorf, Ruth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2007
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cellsF Philipp Seib, Arwyn T Jones, Ruth Duncan
The New Zealand Medical Journal|November 20, 2025
Bridging the gap in trauma care across New ZealandLuke Barker, Ruth Duncan, James McKay, et al.
Journal of Drug Targeting|November 10, 2006
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicinF Philipp Seib, Arwyn T Jones, Ruth Duncan
Bioconjugate Chemistry|November 20, 2003
Polyacetal-doxorubicin conjugates designed for pH-dependent degradationRyan Tomlinson, Jorge Heller, Steve Brocchini, et al.
Journal of Drug Targeting|December 29, 2004
Polyacetal-diethylstilboestrol: a polymeric drug designed for pH-triggered activationMaría J Vicent, Ryan Tomlinson, Steve Brocchini, et al.
Journal of Drug Targeting|March 17, 2007
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imagingMaria Manunta, Lorella Izzo, Ruth Duncan, et al.
Macromolecular Bioscience|November 20, 2008
Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linkerNathalie Lavignac, Johanna L Nicholls, Paolo Ferruti, et al.
Molecular Pharmaceutics|February 19, 2010
Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapyElaine L Ferguson, Simon C W Richardson, Ruth Duncan
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of Drug Targeting|November 10, 2006
Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunitiesRuth Duncan, Helmut Ringsdorf, Ronit Satchi-Fainaro
Advanced Drug Delivery Reviews|August 18, 2009
Polymer therapeutics: clinical applications and challenges for developmentMaría J Vicent, Helmut Ringsdorf, Ruth Duncan
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2007
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cellsF Philipp Seib, Arwyn T Jones, Ruth Duncan
The New Zealand Medical Journal|November 20, 2025
Bridging the gap in trauma care across New ZealandLuke Barker, Ruth Duncan, James McKay, et al.
Journal of Drug Targeting|November 10, 2006
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicinF Philipp Seib, Arwyn T Jones, Ruth Duncan
Bioconjugate Chemistry|November 20, 2003
Polyacetal-doxorubicin conjugates designed for pH-dependent degradationRyan Tomlinson, Jorge Heller, Steve Brocchini, et al.
Journal of Drug Targeting|December 29, 2004
Polyacetal-diethylstilboestrol: a polymeric drug designed for pH-triggered activationMaría J Vicent, Ryan Tomlinson, Steve Brocchini, et al.
Journal of Drug Targeting|March 17, 2007
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imagingMaria Manunta, Lorella Izzo, Ruth Duncan, et al.
Macromolecular Bioscience|November 20, 2008
Poly(amidoamine) conjugates containing doxorubicin bound via an acid-sensitive linkerNathalie Lavignac, Johanna L Nicholls, Paolo Ferruti, et al.
Molecular Pharmaceutics|February 19, 2010
Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapyElaine L Ferguson, Simon C W Richardson, Ruth Duncan
Pageof 7